The Most Characteristic Metabolic Abnormality in Glucagonoma
The most characteristic metabolic abnormality in glucagonoma is hypoaminoacidemia (option b). This distinctive feature is a hallmark of the glucagonoma syndrome and differentiates it from other pancreatic neuroendocrine tumors.
Metabolic Features of Glucagonoma
- Glucagonoma is a rare alpha-cell tumor of the pancreas that produces excess glucagon, leading to a constellation of metabolic abnormalities 1, 2
- The characteristic metabolic profile includes:
Why Hypoaminoacidemia is the Most Characteristic Finding
- Excess glucagon dramatically increases amino acid catabolism, with studies showing the percentage of leucine flux oxidized can be 50% greater than normal values 3
- This increased amino acid breakdown leads to profound hypoaminoacidemia, which contributes to the characteristic necrolytic migratory erythema (NME) skin rash 2, 5
- While hyperglycemia occurs in glucagonoma, it is typically mild compared to other forms of diabetes, and is not the most distinctive metabolic feature 1, 2
Distinguishing from Other Options
- Hypoglycemia (option a): Incorrect - glucagonoma causes hyperglycemia, not hypoglycemia, as glucagon opposes insulin action and promotes hepatic glucose production 6
- Hypocholesterolemia (option c): While present in glucagonoma syndrome, it is not as characteristic or consistent as hypoaminoacidemia 1
- Hypercholesterolemia (option d): Incorrect - glucagonoma typically causes hypocholesterolemia, not hypercholesterolemia 1, 4
Clinical Significance
Early recognition of hypoaminoacidemia in patients with suspicious symptoms can lead to earlier diagnosis of glucagonoma 5, 4
The metabolic abnormalities of glucagonoma syndrome include:
The definitive treatment for glucagonoma is surgical resection, which can resolve both cutaneous manifestations and metabolic abnormalities 5, 4